Portal de investigación
Vaccination against Community-Acquired Pneumonia in Spanish Adults: Practical Recommendations by the NeumoExperts Prevention Group.
Fecha de publicación:
Fecha Ahead of Print:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Redondo, Esther
- Rivero-Calle, Irene
- Mascaros, Enrique
- Ocaña D
- Jimeno, Isabel
- Gil, Angel
- Diaz-Maroto, Jose Luis
- Onieva-Garcia, Maria Angeles
- Gonzalez-Romo, Fernando
- Yuste, Jose
- Martinon-Torres, Federico
Abstract
In the adult population, community-acquired pneumonia (CAP) is a serious disease that is responsible for high morbidity and mortality rates, being frequently associated with multidrug resistant pathogens. The aim of this review is to update a practical immunization prevention guideline for CAP in Spain caused by prevalent respiratory pathogens, based on the available scientific evidence through extensive bibliographic review and expert opinion. The emergence of COVID-19 as an additional etiological cause of CAP, together with the rapid changes in the availability of vaccines and recommendations against SARS-CoV-2, justifies the need for an update. In addition, new conjugate vaccines of broader spectrum against pneumococcus, existing vaccines targeting influenza and pertussis or upcoming vaccines against respiratory syncytial virus (RSV) will be very useful prophylactic tools to diminish the burden of CAP and all of its derived complications. In this manuscript, we provide practical recommendations for adult vaccination against the pathogens mentioned above, including their contribution against antibiotic resistance. This guide is intended for the individual perspective of protection and not for vaccination policies, as we do not pretend to interfere with the official recommendations of any country. The use of vaccines is a realistic approach to fight these infections and ameliorate the impact of antimicrobial resistance. All of the recently available scientific evidence included in this review gives support to the indications established in this practical guide to reinforce the dissemination and implementation of these recommendations in routine clinical practice.
Datos de la publicación
- ISSN/ISSNe:
- 2079-6382, 2079-6382
- Tipo:
- Article
- Páginas:
- -
- PubMed:
- 36671339
- Enlace a otro recurso:
- www.scopus.com
- Factor de Impacto:
- 0,785 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
Antibiotics-Basel MDPI
Citas Recibidas en Web of Science: 16
Documentos
- No hay documentos
Filiaciones
Keywords
- COVID-19; SARS-CoV-2 vaccines; VRS; antimicrobial resistance; community-acquired pneumonia; influenza vaccination; influenza vaccines; pertussis; pneumococcal conjugate vaccines; pneumococcal polysaccharide vaccine